会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • VEGF-Modulated Genes and Methods Employing Them
    • VEGF调控基因和方法
    • US20080166724A1
    • 2008-07-10
    • US11932133
    • 2007-10-31
    • Hans-Peter GerberLuca Rastelli
    • Hans-Peter GerberLuca Rastelli
    • C12Q1/68C12Q1/02G01N33/574
    • C07K14/47A61K38/00
    • The present invention provides methods for modulating angiogenesis and/or apoptosis comprising modulating the activity of at least one VEGF-modulated gene polypeptide. The invention also provides pharmaceutical compositions for modulating angiogenesis and apoptosis for the prevention or treatment of diseases associated with VEGF-modulated genes expression. The invention also provides diagnostic assays that use VEGF-modulated gene polynucleotides that hybridize with naturally occurring sequences encoding VEGF-modulated genes and antibodies that specifically bind to the protein.The invention also provides novel human and mouse arginine-rich proteins (ARPs) and nucleotide sequences. The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding ARPs and for a method for producing the protein.
    • 本发明提供调节血管生成和/或凋亡的方法,包括调节至少一种VEGF调节的基因多肽的活性。 本发明还提供用于调节血管发生和凋亡以用于预防或治疗与VEGF调节的基因表达相关的疾病的药物组合物。 本发明还提供使用VEGF调节的基因多核苷酸的诊断测定法,其与编码VEGF调节的基因的天然存在的序列和与蛋白质特异性结合的抗体杂交。 本发明还提供新的人和小鼠富含精氨酸的蛋白质(ARP)和核苷酸序列。 本发明提供了基因工程表达载体和宿主细胞,其包含编码ARP的核酸序列和用于产生蛋白质的方法。
    • 4. 发明授权
    • Methods of prevention and treatment of inflammatory bowel disease
    • 预防和治疗炎症性肠病的方法
    • US06982250B2
    • 2006-01-03
    • US10011364
    • 2001-11-16
    • Henry LichensteinMichael Jeffers
    • Henry LichensteinMichael Jeffers
    • A61K38/00C07K17/00
    • C07K14/50A61K38/00C07K14/49C07K14/51C07K14/52
    • The present invention is based upon methods of treating inflammatory conditions in the intestinal tract of mammals using growth factor related polypeptides. The invention includes methods of reducing the morality rate or delaying mortality in a subject suffering from an inflammatory pathology. Methods of using fibroblast growth factor-CX (FGF-CX) polynucleotide sequences and the FGF-CX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, are claimed in the invention. Similarly, methods of using FCTRX polynucleotide sequences and the FCTRX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, alone or in combination, are also claimed in the invention. FCTRX collectively refers to any of six variant FCTRX sequences, variously designated FCTR1, FCTR2, FCTR3, FCTR4, FCTR5 and FCTR6.
    • 本发明是基于使用生长因子相关多肽治疗哺乳动物肠道炎症状况的方法。 本发明包括降低患有炎性病理学的受试者的道德率或延缓死亡率的方法。 在本发明中要求使用成纤维细胞生长因子CX(FGF-CX)多核苷酸序列和由这种核酸序列编码的FGF-CX多肽或其变体,片段和同系物的方法。 类似地,在本发明中还要求保护使用FCTRX多核苷酸序列和由此类核酸序列编码的FCTRX多肽,或其变体,片段和同源物单独或组合使用的方法。 FCTRX统称为六种变体FCTRX序列中的任何一种,分别为FCTR1,FCTR2,FCTR3,FCTR4,FCTR5和FCTR6。